Key terms
About MNMD
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn in 2019 and is headquartered in New York, NY.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest MNMD news
Apr 15
6:28am ET
Mind Medicine initiated with an Outperform at Leerink
Apr 11
10:24am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Apr 01
7:37pm ET
Mind Medicine Inc. Statement Inaccessible
Apr 01
5:03pm ET
Mind Medicine announces voluntary delisting from Cboe Canada
Mar 21
10:52am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Mar 21
8:46am ET
Largest borrow rate increases among liquid names
Mar 15
12:05pm ET
MindMed call volume above normal and directionally bullish
Mar 08
7:46am ET
Mind Medicine price target raised to $16 from $9 at Canaccord
Mar 07
4:23pm ET
Mind Medicine price target raised to $22 from $15 at RBC Capital
Mar 07
1:09pm ET
Rising High: Exclusive talk with multi-state operator C3 Industries
Mar 07
11:03am ET
Mind Medicine price target raised to $36 from $25 at Roth MKM
Mar 07
10:46am ET
Rising High: Exclusive talk with vape tech developer Ispire Technology
Mar 07
10:07am ET
MindMed Files Form 8-K with SEC, Signals Growth
Mar 07
8:00am ET
Mind Medicine up 26% after announcing FDA breakthrough designation for MM120
Mar 07
7:58am ET
Mind Medicine 16.67M share Spot Secondary priced at $6.00
Mar 07
7:50am ET
Mind Medicine to host conference call
Mar 07
6:02am ET
Mind Medicine receives FDA breakthrough designation for MM120
Mar 07
12:15am ET
Mind Medicine to host conference call
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 29
11:29am ET
Here’s What You Missed in Cannabis, Psychedelics This Week
Feb 28
7:40am ET
MindMed Announces Breakthrough GAD Treatment Results
Feb 15
4:55am ET
Mind Medicine management to meet with Oppenheimer
Feb 14
8:44am ET
Mind Medicine management to meet with Oppenheimer
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 08
11:22am ET
Rising High: Exclusive talk with house of brands Carma HoldCo
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:35am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
Feb 01
11:21am ET
Rising High: Exclusive talk with drug manufacturer Optimi Health
No recent press releases are available for MNMD
MNMD Financials
Key terms
Ad Feedback
MNMD Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
MNMD Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
